Home > Insider Trading > Filing (0001181431-10-022273)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138412	Genoptix Inc	GXDX	Services-Medical Laboratories (8071)	330840570

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1414894	V Christian Kuhlen	C/O Genoptix, Inc. 1811 Aston Avenue Carlsbad CA 92008	Vp, Gen Counsel & Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-19	940	$9.03	13,876	No	4	M	Direct
Common Stock	Disposition	2010-04-19	940	$38.22	12,936	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2010-04-19	940	$0.00	940	$9.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,453		2017-09-11	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2009, as amended.
The range of sale prices received is $38.135 to $38.35. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
1/4th of the shares subject to the stock option vested and became exercisable on September 12, 2008. The remaining shares vest in equal monthly installments over the next 3 years.